about
Oral contraceptive use before first birth and risk of breast cancer: a case control studySelf-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device.Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma riskA prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomasBreast carcinoma detection modes and death in a female population in relation to population-based mammography screening.Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.Low proportion of false-negative smears in the Finnish program for cervical cancer screening.Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up.Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case-Control Study.Cancer patient survival--patterns, comparisons, trends--a population-based Cancer Registry study in Finland.Improving cervical cancer screening attendance in Finland.A randomised public-health trial on automation-assisted screening for cervical cancer in Finland: performance with 470,000 invitations.Cancer incidence following chlorophenol exposure in a community in southern Finland.Mortality audit of the Finnish cervical cancer screening program.Serum p53 accumulation and altered antibody responses to Epstein-Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin.Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females - Post-hoc analysis of a community-randomized clinical trial (II).Age-specific effectiveness of the Finnish cervical cancer screening programme.The risk of cervical atypia in oral contraceptive users.Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective StudiesGlioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in FinlandHarmonization may be counterproductive--at least for parts of Europe where public health research operates effectivelyIndependent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: A prospective nested case–control studyEvaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years laterGender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessingPopulation-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacyOccurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: interaction with HPV seropositivityProspects for phase III-IV HPV vaccination trials in the Nordic countries and in EstoniaImpact of screening examinations on survival in familial adenomatous polyposisProcess indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000Survival of in situ carcinoma of cervix uteri: a 50-year follow-up in FinlandMaternal human polyomavirus infection and risk of neuroblastoma in the childHuman papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control studyEnsuring quality in studies linking cancer registries and biobanksLarge performance variation does not affect outcome in the Finnish cervical cancer screening programme
P50
Q24800615-633EA1D7-C29D-44FF-8BC8-6915B25991EEQ35958230-53A88D52-F3AF-4CEE-BA2D-7DBE5CCD769DQ36615392-A51B7462-EC28-467B-9D6E-ABAAEA2FAE87Q36645918-27579B73-7717-4240-8AFA-78356D0BA06EQ36699168-43142C96-C9AF-4F9A-B9AE-D55215244CD2Q37850050-0EECA5FE-5BC7-4F1A-9E67-5C68B5C6A1CBQ37855991-DE548606-987A-4BCF-BF0D-722578A9BC7CQ38397934-B3F84ADB-6E4C-4582-BACA-268250DB31FBQ38417922-BD9F73E2-C55D-4AF0-956A-2C546CF82BCEQ38618078-0A6A2D1E-AB77-46D6-899D-CD92FAD2E902Q39514544-7403A322-D43A-4717-825D-76EFBE500EAAQ40780190-2C2C06F7-6FE2-46F7-9156-543F95DE4D5AQ40808657-4BA92BE2-8540-4877-B200-B74FB0358460Q42680014-588609EE-EC49-49EA-974D-1070AF9A11EBQ43906551-5707EECA-037B-48F7-BECA-41E03C37CC82Q44735906-3707A9DC-AEFF-4257-931C-CA012ECEE2B1Q44929237-D669E795-4A63-4546-AC10-FA0E1CB65374Q45771168-A1BF6896-5890-49DD-868F-B71AD047B945Q47242967-B981FC79-4896-4C26-8C2D-4ACDB91E956FQ47548387-D5841056-229C-49B1-B99C-BD70C8BBBBA0Q49135434-6E452DC8-07C6-43F3-B6C8-6710A6AEACE2Q50056808-A3FE5FBA-B830-4155-A28B-7372878B3AEDQ57312948-78285D5D-9F5F-4BB2-B781-E36F7867F68FQ57472010-41EFE8A9-972D-4AE8-903B-E6B582507653Q57543425-EFE05AA6-D243-4FF7-94B3-095D67CD4B3AQ58352169-65E14CEE-12FB-4E5C-97EC-FDE0565DC71CQ58813765-6D232079-8BE2-448F-A53D-B190F074706FQ59360234-3E3F4CC1-B1AB-418C-91E5-D94B0B8CA4AFQ59650617-8B116135-9DC7-4B39-926F-A1A680AD9BECQ59650618-101AC758-DFC6-40B8-A49D-E653C5072EBDQ64116960-A1C9FA5A-41B4-4D29-B0B8-EA994299F128Q73220097-9AE6FC9E-59D0-46CE-BAE8-773A6E1635B1Q73223002-E64DB25A-2F29-4EFB-BA95-97B3B2A6A8F1Q73490436-43A02E02-FC1D-4AFA-BC14-E05CF0AC14CDQ80516063-5E4E686E-F851-411D-AF67-1F204C450FCBQ80602556-90662A0B-724B-443F-B0E8-8222C02D2AFFQ80801762-3F1513C9-9573-4905-B226-C8533ED50573Q81645152-EA4EFC7A-619D-4C48-95A5-AC1C812284CCQ82442383-53706B51-EDFB-46F6-9529-0F3927ADFA1CQ83262215-8A42C12A-3ABF-4B29-A27E-7B68E7DF6549
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tapio Luostarinen
@ast
Tapio Luostarinen
@en
Tapio Luostarinen
@es
Tapio Luostarinen
@nl
type
label
Tapio Luostarinen
@ast
Tapio Luostarinen
@en
Tapio Luostarinen
@es
Tapio Luostarinen
@nl
prefLabel
Tapio Luostarinen
@ast
Tapio Luostarinen
@en
Tapio Luostarinen
@es
Tapio Luostarinen
@nl
P106
P1153
7004252373
P31
P496
0000-0003-3231-8550